Complete response of colorectal liver metastases after chemotherapy: Does it mean cure?

Journal of Clinical Oncology

Volumn 24, Issue 24, 2006, Pages 3939-3945

  Benoist, Stéphane ^a   Brouquet, Antoine ^a   Penna, Christophe ^a   Julié, Catherine ^a   El Hajjam, Mostafa ^a   Chagnon, Sophie ^a   Mitry, Emmanuel ^a   Rougier, Philippe ^a   Nordlinger, Bernard ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CELL VIABILITY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RADIOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 33748460684     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.8727     Document Type: Article

References (36)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
2. Stangl R, Altendorf-Hofmann A, Charnley RM, et al: Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410, 1994
3. Leonard GD, Brenner B, Kemeny NE: Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23:2038-2048, 2005
4. Scheele J, Stang R, Altendorf-Hofmann A, et al: Resection of colorectal liver metastases. World J Surg 19:59-71, 1995
5. Fortner JG, Silva JS, Cox EB, et al: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: Treatment by hepatic resection. Ann Surg 199:306-316, 1984
6. Scheele J: Hepatectomy for liver metastases. Br J Surg 80:274-276, 1993
7. Petrelli NJ, Abbruzzese J, Mansfield P, et al: Hepatic resection: The last surgical frontier for colorectal cancer. J Clin Oncol 23:4475-4477, 2005
8. Meric F, Patt YZ, Curley SA, et al: Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7:490-495, 2000
9. Adam R, Delvart V, Pascal G, et al: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240:644-657, 2004
10. Allen PJ, Kemeny N, Jarnagin W, et al: Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7:109-115, 2003
11. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216, 2000
12. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
13. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 355:1041-1047, 2000
14. Adam R, Pascal G, Castaing D, et al: Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052-1061, 2004
15. Rivoire M, De Cian F, Meeus P, et al: Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 95:2283-2292, 2002
16. Bhattacharjya S, Bhattacharjya T, Baber S, et al: Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection. Br J Surg 91:1361-1369, 2004
17. Bipat S, van Leeuwen MS, Comans EF, et al: Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237:123-131, 2005
18. Valls C, Andia E, Sanchez A, et al: Hepatic metastases from colorectal cancer: Preoperative detection and assessment of respectability with helical CT. Radiology 218:55-60, 2001
19. Elias D, Sideris L, Pocard M, et al: Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy and not treated when performing percutaneous radiofrequency ablation. Ann Surg Oncol 12:298-302, 2005
20. Bennett JJ, Cao D, Posner MC: Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases. J Surg Oncol 92:64-69, 2005
21. Fernandez FG, Ritter J, Goodwin JW, et al: Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853, 2005
22. Shirkhoda A, Baird S: Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings. Abdom Imaging 19:39-42, 1994
23. Bartolozzi C, Donati F, Cioni D, et al: Detection of colorectal liver metastases: A prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 14:14-20, 2004
24. Ward J, Robinson PJ, Guthrie JA, et al: Liver metastases in candidates for hepatic resection: Comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237:170-180, 2005
25. Sahani DV, Kalva SP, Tanabe KK, et al: Intraoperative US in patients undergoing surgery for liver neoplasms: Comparison with MR imaging. Radiology 232:810-814, 2004
26. Fernandez FG, Debrin JA, Linehan DC, et al: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438-450, 2004
27. Colucci G, Gebbia V, Paoletti G, et al: Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23:4866-4875, 2005
28. Kohne CH, van Cutsem E, Wils J, et al: Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol 23:4856-4865, 2005
29. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004
30. Trillet-Lenoir V, Freyer G, Kaemmerlen P, et al: Assessment of tumour response to chemotherapy for metastatic colorectal cancer: Accuracy of the RECIST criteria. Br J Radiol 75:903-908, 2002
31. Watanabe H, Yamamoto S, Kunitoh H, et al: Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci 94:1015-1020, 2003
32. Khatri VP, Petrelli NJ, Belghiti J: Extending the frontiers of surgical therapy for hepatic colorectal metastases: Is there a limit? J Clin Oncol 23:8490-8499, 2005
33. Bilchik AJ, Postone G, Curley SA, et al: Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note. J Clin Oncol 23:9073-9078, 2005
34. Bathe OF: Preoperative chemotherapy for liver metastases: A contemporary approach giving rise to new questions. J Surg Oncol 86:1-3, 2004
35. Pozzo C, Basso M, Cassano A, et al: Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15:933-939, 2004
36. Elias D, Youssef O, Sideris L, et al: Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 86:4-9, 2004